GMPs

Home » Topics » Pharmaceuticals » GMPs

July 6, 2020
FDA Outlines GMPs for COVID-19 Infections in Workers
The FDA has released guidance for drugmakers on good manufacturing practices (GMPs) for responding to COVID-19 infection in employees.
July 6, 2020
USP Supports Use of Crab-Derived Reagents for Drug Tests
After a lengthy review, the U.S. Pharmacopeia (USP) has decided to continue recommending the use of decades-old reagents derived from horseshoe crab blood for detecting endotoxins in drugs rather than press for the use of new synthetic substitutes.
June 22, 2020
FDA Outlines GMPs for Drugmakers Dealing With COVID-19 Infections in Workers
The FDA on Friday released guidance for drugmakers on good manufacturing practices (GMPs) for responding to COVID-19 infection in employees.

June 5, 2020
USP Supports Continued Use of Crab-Derived Reagents for Drug Tests
April 17, 2020
FDA Eases Requirements for Some Compounded COVID-19 Drugs
September 26, 2018
FDA Warns Indian OTC Facility for Quality Violations
September 25, 2018
FDA Warns Indian OTC Facility for Quality Violations
February 15, 2018
FDA to Define GMPs for Outsourcing Facilities

December 19, 2017
European Commission Issues New GMP Guidelines for Advanced Therapies
December 11, 2017
Morrison Says ORA Reorganization Will Mean More Foreign Inspections
December 11, 2017
Warning Letter Roundup: FDA Flags Labeling, Sterility, Other Violations
December 11, 2017
European Commission Issues New GMP Guidelines for Advanced Therapies
December 11, 2017
FDA to Recognize GMP Inspections From Eight EU Countries